JPMDL Won’t Expedite Hearing On Viagra Skin Cancer MDL Motion

(January 4, 2016, 11:32 AM EST) -- WASHINGTON, D.C. — The Judicial Panel on Multidistrict Litigation (JPMDL) on Dec. 29 denied a joint request by Pfizer Inc. and Viagra plaintiffs to place a motion for a skin cancer multidistrict litigation on the panel’s Jan. 28 agenda (In Re: Viagra Products Liability Litigation, MDL Docket No. 2691, JPMDL).

In a Dec. 28 joint motion, the parties asked the JPMDL to place the MDL motion on the Jan. 28 calendar to avoid the delay of waiting until the panel’s next hearing in March. They said...
To view the full article, register now.